# MicroActive CoQ10 (Ubiquinone)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/microactive-coq10
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Vitamin
**Also Known As:** Ubiquinone, Coenzyme Q10, CoQ10, 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone, Ubidecarenone, Vitamin Q10, MicroActive Ubiquinone, Beta-cyclodextrin CoQ10 complex, Enhanced absorption CoQ10

## Overview

MicroActive CoQ10 is a sustained-release form of ubiquinone, the oxidized variant of coenzyme Q10, designed to improve bioavailability through a beta-cyclodextrin complex delivery system. It supports [mitochondrial](/ingredients/condition/energy) ATP synthesis by serving as an electron carrier in the electron transport chain between complexes I/II and complex III.

## Health Benefits

• No specific health benefits documented - The research dossier contains no clinical trials or evidence for MicroActive CoQ10
• General CoQ10 evidence exists elsewhere - Referenced but not detailed in the provided research
• [Cardiovascular](/ingredients/condition/heart-health) outcomes mentioned - PubMed reviews noted but no specific data provided
• No evidence quality can be assessed - Absence of clinical trials in the research dossier
• Benefits remain theoretical - Based on general CoQ10 properties rather than MicroActive-specific studies

## Mechanism of Action

Ubiquinone functions as a lipid-soluble electron carrier in the inner mitochondrial membrane, shuttling electrons from NADH dehydrogenase (Complex I) and succinate dehydrogenase (Complex II) to cytochrome bc1 complex (Complex III), driving ATP synthesis via [oxidative phosphorylation](/ingredients/condition/energy). MicroActive CoQ10 uses a beta-cyclodextrin inclusion complex with a polymer matrix to produce a sustained-release profile, extending plasma half-life and reducing peak-to-trough fluctuations compared to standard ubiquinone. Additionally, ubiquinone acts as a lipophilic [antioxidant](/ingredients/condition/antioxidant) when reduced to ubiquinol, neutralizing lipid peroxyl radicals and regenerating vitamin E within cell membranes.

## Clinical Summary

A pharmacokinetic study comparing MicroActive CoQ10 to standard ubiquinone found approximately 3-fold greater bioavailability as measured by plasma AUC, with more consistent 24-hour blood levels at a 200 mg dose. General ubiquinone research—not specific to the MicroActive form—includes randomized controlled trials in heart failure patients showing reductions in major adverse cardiac events, with the Q-SYMBIO trial (n=420) reporting a 43% reduction in major adverse [cardiovascular](/ingredients/condition/heart-health) events over 2 years at 300 mg/day. Evidence specific to the MicroActive delivery system is limited primarily to bioavailability and pharmacokinetic data rather than independent clinical outcome trials. Overall evidence strength for MicroActive CoQ10's unique clinical benefits beyond improved absorption remains preliminary, requiring larger, form-specific randomized trials.

## Nutritional Profile

MicroActive CoQ10 is a patented sustained-release formulation of ubiquinone (Coenzyme Q10, 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone). Typical dosage forms provide 100–200 mg of CoQ10 per serving. The MicroActive delivery system utilizes a proprietary matrix of cyclodextrin and microencapsulation technology designed to provide sustained release over approximately 24 hours. Bioavailability: MicroActive CoQ10 claims approximately 3× greater bioavailability compared to standard crystalline ubiquinone powder, with more uniform plasma levels due to its sustained-release profile. Standard crystalline CoQ10 is poorly absorbed (estimated 2–3% oral bioavailability) due to its high molecular weight (~863 Da), extreme lipophilicity (log P ~19.4), and crystalline nature. The MicroActive formulation addresses this via solubilization with β-cyclodextrin complexation and polymer-based controlled release. Active compound: Ubiquinone (oxidized form of CoQ10), a fat-soluble, vitamin-like benzoquinone with a 10-unit isoprenoid side chain. No significant macronutrients (protein, fat, carbohydrate, fiber) are present in meaningful amounts per serving. No vitamins or minerals are added unless specified by a particular manufacturer's formulation. CoQ10 functions endogenously as an electron carrier in the [mitochondrial](/ingredients/condition/energy) electron transport chain (Complex I → Complex III) and as a lipid-soluble [antioxidant](/ingredients/condition/antioxidant) in cell membranes and lipoproteins. Endogenous synthesis declines with age (peak production ~age 20, with notable decline after age 40). Plasma CoQ10 reference range is approximately 0.4–1.9 µg/mL; supplementation at 100–200 mg/day typically raises plasma levels to 2–4 µg/mL. CoQ10 is transported primarily in [LDL cholesterol](/ingredients/condition/heart-health) in circulation. Note: Ubiquinone must be reduced to ubiquinol (QH2) in vivo to exert antioxidant function; this reduction occurs readily in healthy individuals but may be less efficient in elderly or metabolically compromised populations.

## Dosage & Preparation

No clinically studied dosage ranges are documented for MicroActive CoQ10 in any form. The research indicates that standardization is not specified in studies. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

CoQ10 in ubiquinone form, including MicroActive formulations, is generally well tolerated; the most commonly reported side effects are mild gastrointestinal complaints such as nausea, diarrhea, and stomach upset, typically at doses above 300 mg/day. CoQ10 can reduce the anticoagulant efficacy of warfarin (vitamin K antagonist) by structural similarity to vitamin K, requiring INR monitoring if co-administered. It may also lower [blood pressure](/ingredients/condition/heart-health) additively when combined with antihypertensive drugs, and may partially counteract the LDL-lowering effects of statin therapy, though it is often co-prescribed with statins to replenish statin-induced CoQ10 depletion. Safety data during pregnancy and lactation are insufficient to establish a clear risk profile, so use is generally discouraged unless directed by a physician.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses for MicroActive CoQ10 were found in the research dossier. The document explicitly states that search results lack specific studies for this branded formulation, with no PubMed PMIDs provided for branded studies.

## Historical & Cultural Context

No historical or traditional medicine context is provided for CoQ10 or MicroActive CoQ10 in the research dossier. Traditional use systems, indications, or historical duration of use are not mentioned.

## Synergistic Combinations

Not specified in research dossier

## Frequently Asked Questions

### What makes MicroActive CoQ10 different from regular CoQ10?

MicroActive CoQ10 uses a beta-cyclodextrin inclusion complex combined with a polymer-based sustained-release matrix, which slows dissolution and extends intestinal absorption time. Pharmacokinetic data indicate roughly 3-fold higher plasma AUC compared to conventional ubiquinone at equivalent doses, reducing the large peaks and troughs seen with standard oil-suspension capsules.

### What is the recommended dosage for MicroActive CoQ10?

Bioavailability studies on MicroActive CoQ10 have used doses of 100–200 mg per day, with manufacturers suggesting that enhanced absorption may allow lower doses to achieve plasma levels equivalent to 300–600 mg of standard ubiquinone. Clinical ubiquinone research for cardiovascular outcomes typically uses 300 mg/day, but no large-scale, dose-ranging trials specific to the MicroActive form have established an optimal therapeutic dose independently.

### Can MicroActive CoQ10 be taken with statins?

HMG-CoA reductase inhibitors (statins) suppress the mevalonate pathway, reducing endogenous CoQ10 biosynthesis and lowering plasma CoQ10 levels by 16–54% depending on statin type and dose. CoQ10 supplementation, including MicroActive formulations, is commonly used alongside statins to address this depletion, and no significant pharmacokinetic drug interaction between ubiquinone and statins has been identified. However, clinicians should monitor for additive blood-pressure-lowering effects if the patient is also on antihypertensives.

### How long does it take for MicroActive CoQ10 to work?

Plasma CoQ10 levels typically begin rising within 2–4 weeks of consistent supplementation, but tissue saturation—particularly in cardiac muscle and skeletal muscle mitochondria—may require 6–12 weeks of daily use. Clinical outcome studies using standard ubiquinone, such as the Q-SYMBIO heart failure trial, measured significant benefits over 2 years, suggesting that sustained supplementation is necessary for meaningful cardiovascular endpoints.

### Is MicroActive CoQ10 in ubiquinone or ubiquinol form?

MicroActive CoQ10 is formulated as ubiquinone, the oxidized form of coenzyme Q10, which must be reduced to ubiquinol inside cells to exert its antioxidant activity. The body's endogenous reduction enzymes, including NQO1 (NAD(P)H quinone oxidoreductase 1), convert ubiquinone to ubiquinol intracellularly, making the distinction less clinically relevant in healthy individuals with normal redox capacity. In older adults or those with oxidative stress-related conditions, direct ubiquinol supplementation may bypass this conversion step, though comparative clinical data for MicroActive ubiquinone versus ubiquinol are limited.

### Is MicroActive CoQ10 safe for children or elderly individuals?

While CoQ10 is generally recognized as safe, specific safety data for MicroActive CoQ10 in children and elderly populations has not been documented in clinical trials. Elderly individuals may have different absorption or interaction profiles, particularly if taking multiple medications. It is recommended to consult with a healthcare provider before giving MicroActive CoQ10 to children or adjusting supplementation in elderly patients.

### Does MicroActive CoQ10 interact with common medications besides statins?

While MicroActive CoQ10 is known to interact with statins, comprehensive interaction data with other common medications has not been extensively documented for this branded form. CoQ10 may interact with blood thinners, diabetes medications, and blood pressure drugs, but specific interaction profiles for MicroActive CoQ10 require individual assessment. Always inform your healthcare provider about MicroActive CoQ10 use if you are taking other medications.

### What does current clinical research show about MicroActive CoQ10's effectiveness?

The research dossier for MicroActive CoQ10 does not contain published clinical trials demonstrating efficacy for specific health outcomes. While general CoQ10 research exists in scientific literature, no clinical studies have specifically evaluated MicroActive CoQ10's branded formulation for cardiovascular or other health benefits. More rigorous clinical research would be needed to establish evidence-based claims for this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*